Zemplar
Product Images NDC 0074-4314

7 FDA label images from Abbvie Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Zemplar (NDC 0074-4314). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Abbvie Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

The Following Structural Formula: Paricalcitol Is A White, Crystalline Powder With The Empirical Formula Of C27h44o3, Which Corresponds To A Molecular Weight Of 416.64. Paricalcitol Is Chemically Designated As 19-nor-1α,3β,25-trihydroxy-9,10-secoergosta-5(z),7(e),22(e). (Zemplar Capsules Spl 01)

The Following Structural Formula: Paricalcitol Is A White, Crystalline Powder With The Empirical Formula Of C27h44o3, Which Corresponds To A Molecular Weight Of 416.64. Paricalcitol Is Chemically Designated As 19-nor-1α,3β,25-trihydroxy-9,10-secoergosta-5(z),7(e),22(e). (Zemplar Capsules Spl 01)
Chemical structure of the active ingredient in Zemplar, a vitamin D analog used in drug formulations by AbbVie Inc.*
FDA Label Image

Figure 1 (Zemplar Capsules Spl 02)

Figure 1 (Zemplar Capsules Spl 02)
A line graph comparing the levels of intact parathyroid hormone (iPTH) in pg/mL over 23 weeks between Zemplar treatment and placebo groups. The graph shows time (weeks) on the x-axis and iPTH concentration on the y-axis, illustrating a decrease in iPTH for the Zemplar group and a relatively stable iPTH for the placebo group.*
FDA Label Image

Figure 2 (Zemplar Capsules Spl 03)

Figure 2 (Zemplar Capsules Spl 03)
A line graph comparing intact parathyroid hormone (iPTH) levels in pg/mL over 12 weeks between Zemplar and placebo groups. The graph shows iPTH mean values with error bars for each week, illustrating a decline and stabilization in the Zemplar group compared to a generally higher trend in the placebo group.*
FDA Label Image

Ndc 0074–9036–30 Zemplar® (paricalcitol) Capsules 1 Mcg 30 Capsules Rx Only Abbvie (Zemplar Capsules Spl 04)

Ndc 0074–9036–30 Zemplar® (paricalcitol) Capsules 1 Mcg 30 Capsules Rx Only Abbvie (Zemplar Capsules Spl 04)
Zemplar 1 mcg capsules packaging label showing the active ingredient paricalcitol. The label indicates a quantity of 30 capsules, prescription only, manufactured for AbbVie Inc. Storage instructions and product origin (Ireland) are also included along with barcodes and the AbbVie logo.*
FDA Label Image

Ndc 0074–9037–30 Zemplar® (paricalcitol) Capsules 2 Mcg 30 Capsules Rx Only Abbvie (Zemplar Capsules Spl 05)

Ndc 0074–9037–30 Zemplar® (paricalcitol) Capsules 2 Mcg 30 Capsules Rx Only Abbvie (Zemplar Capsules Spl 05)
Zemplar (paricalcitol) capsules 2 mcg label shows product name, active ingredient, strength, quantity of 30 capsules, and Rx only status. Label includes storage instructions, manufacturer AbbVie Inc., and NDC 0074-9037-30. Barcode and placeholder for 2D barcode also appear.*
FDA Label Image

Description: Zemplar-1mcg-30ct-capsules (Zemplar Capsules Spl 06)

FDA Label Image

Ndc 0074–4314–30 Zemplar® (paricalcitol) Capsules 2 Mcg 30 Capsules Rx Only Abbvie (Zemplar Capsules Spl 07)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.